| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |